Sage Therapeutics, Inc.·4

Jun 26, 4:02 PM ET

Quirk Michael C. 4

4 · Sage Therapeutics, Inc. · Filed Jun 26, 2025

Insider Transaction Report

Form 4
Period: 2025-06-24
Quirk Michael C.
See Remarks
Transactions
  • Tax Payment

    Common Stock

    2025-06-24$9.22/sh113$1,04230,461 total
Footnotes (1)
  • [F1]On June 24, 2025, the reporting person vested 338 shares of time-based restricted stock units (RSUs) granted on October 28, 2021 under the Sage Therapeutics, Inc. 2014 Stock Option and Incentive Plan. This grant vested 25% on September 24, 2022, and vests quarterly thereafter in twelve equal installments. Represents shares withheld to satisfy tax withholding obligations on the vesting of restricted stock units.

Documents

2 files
  • 4
    primarydocument.xmlPrimary

    PRIMARY DOCUMENT

  • EX-24

    POWER OF ATTORNEY